Search for: "Hyman Phelps McNamara"
Results 41 - 60
of 207
Sort by Relevance
|
Sort by Date
2 Jan 2023, 7:14 pm
Karst (Director, Hyman, Phelps & McNamara P.C.). [read post]
22 Dec 2022, 12:44 am
(Hyman, Phelps & McNamara, P.C., was co-counsel for the Judge Rotenberg Center in this litigation.) [read post]
1 Dec 2022, 7:37 pm
Anne Walsh of Hyman, Phelps & McNamara PC will be presenting on “The Relationship Between Outside Counsel Investigations and Quality System Investigations, and What to Do when they Conflict” as part of the Food and Drug Law Institute’s Enforcement, Litigation, and Compliance Conference on December 7-8 in Washington, DC. [read post]
15 Nov 2022, 2:16 pm
Hyman, Phelps & McNamara, P.C. [read post]
9 Nov 2022, 3:39 pm
As we have done in the past for the initial and each quinquennial reauthorization of the drug and medical device user fee laws—in 1992, 1997, 2002, 2007, 2012, and 2017—Hyman, Phelps & McNamara, P.C. has prepared a detailed Summary and Analysis of FUFRA. [read post]
18 Oct 2022, 12:00 am
Here are a few blogs to help stay connected with the latest happenings in food law: The National Agricultural Law Center: The Ag & Food Law Update Hyman, Phelps & McNamara, P.C. - FDA Law Blog UCLA School of Law Resnick Center for Food Law & Policy - On Food Law Hogan Lovells - Food Law [read post]
16 Oct 2022, 7:12 pm
Karst —Hyman, Phelps & McNamara, P.C. [read post]
29 Sep 2022, 5:56 pm
Hyman, Phelps & McNamara, P.C. [read post]
FDAnews Webinar: Califf’s Post-PDUFA, Post-COVID FDA Agenda: Key Developments, Insights and Analysis
12 Sep 2022, 6:30 pm
Hyman, Phelps & McNamara, P.C. [read post]
3 Aug 2022, 2:21 am
Gibbs, Hyman, Phelps & McNamara, Docket No. 92P-0405 (Aug. 12, 1998) (available here). [read post]
23 Jun 2022, 6:56 pm
Hyman, Phelps & McNamara, P.C. [read post]
15 Jun 2022, 11:10 pm
Hyman, Phelps & McNamara, P.C. [read post]
6 Jun 2022, 5:53 pm
Hyman, Phelps & McNamara, P.C. [read post]
2 Jun 2022, 8:02 pm
Hyman, Phelps & McNamara, P.C. [read post]
31 May 2022, 7:33 pm
Hyman, Phelps & McNamara, P.C. [read post]
23 May 2022, 5:59 am
Hyman, Phelps, and McNamara’s Sara Koblitz will be presenting at the DC Bar’s annual webinar, “FDA for IP Lawyers” on May 25, 2022 with Brian Malkin of McDermott, Will, and Emery. [read post]
17 May 2022, 2:20 am
Hyman, Phelps & McNamara, P.C. [read post]
4 May 2022, 8:26 pm
Hyman, Phelps & McNamara, P.C. is pleased to announce that Sophia Gaulkin will be speaking on an expert panel at the 20th Advanced Summit on Life Sciences Patents, which is being held virtually and in-person in New York City on June 2-3, 2022. [read post]
14 Apr 2022, 10:49 am
Over the course of two days, this event will provide impactful and practical programming all geared towards assessing the implications and imprimaturs of court cases, legislation, and industry behaviors which affect the patent endgame and the pursuit of related profits. 2022 agenda highlights include: The Viability of Written Description as a Compelling Invalidity Defense Clarity On What Satisfies Section 1400(b)’s Venue Requirements in the Hatch-Waxman Context Whether a Skinny Label… [read post]
10 Jan 2022, 12:00 am
Hyman, Phelps & McNamara, P.C. is the largest dedicated FDA law firm, and we need attorneys to help our clients bring pharmaceutical drugs and medical devices to market. [read post]
